Biliary atresia is a progressive fibrosing obstructive cholangiopathy of the intrahepatic and
extrahepatic biliary system, resulting in obstruction of bile flow and neonatal jaundice …

Biliary atresia (BA) and choledochal cysts are diseases of the intrahepatic and extrahepatic
biliary tree. While their exact etiopathogeneses are not known, they should be treated …

Objective To study the outcome of Biliary atresia after Kasai's portoenterostomy and clinical
and biochemical factors affecting the outcome. Methods Medical record review of patients of …

Background The role of routine intraoperative cholangiograms (IOCs) for prevention of bile
duct injury (BDI) is contentious. There are recent reports of limited utility of IOC in preventing …

Objectives Kasai portoenterostomy (KPE) is the primary treatment for biliary atresia (BA) with
subsequent liver transplantation in failed cases. The aim of this work was to study the …

Objectives: Review the morphological classification of biliary atresia. Describe the
radiological, serological, and histopathological tests to diagnose biliary atresia. Summarize …

Purpose Biliary atresia (BA) is the leading cause of neonatal cholestasis (25–45%). The
primary treatment is hepatic portoenterostomy (Kasai procedure), but only 20–40% provide …

Purpose The outcome predictors of Kasai portoenterostomy (KPE) for biliary atresia (BA) are
controversial. This study aimed to identify possible short-term outcome predictors of KPE for …

Purpose Many patients with biliary atresia (BA) after the Kasai procedure (KP) progress to
death or require liver transplantation to achieve long-term survival; however, most cases of …

Background Biliary atresia (BA) causes progressive fibrosis and obliteration of the biliary
tree, resulting in bile stasis and eventual liver dysfunction. It affects 1 in 10,000–18,000 …